Dr Periklis Katopodis, FOOON founder, holding FOOON supplement jars
Dr Periklis KatopodisMolecular Oncologist, Founder and CEO

The founder

Science as a starting point.

FOOON began after a decade in molecular research, and one frustration: the science rarely made it into the supplements people actually use.

10years in molecular research
30+peer reviewed publications
3liposomal formulas: Mind, Body, Sleep

The approach

Built the way a researcher would build it.

01

The research

MSc to PostDoc in molecular oncology: liquid biopsy, diagnostics and clinical trials.

02

The gap

Liposomal delivery is well documented. The products using it were inconsistent, opaque or overpriced.

03

The answer

FOOON: a clear rationale for every ingredient, full transparency, no shortcuts.

My story

From the lab to your morning routine.

My academic path runs from an MSc and MRes to a PhD and PostDoc in the molecular oncology of lung cancer, with a focus on liquid biopsy techniques for cancer diagnostics. Along the way I managed complex clinical trials for leading pharmaceutical companies and worked on advances in digital pathology and molecular biology.

Through those demanding years I relied on multivitamins and nootropics to keep up with training and study. I wanted more energy, better focus and peace of mind, but I was tired of vague promises and generic results. Only liposomal formulations made a noticeable difference, and they came with a high price tag.

That experience became FOOON: a line of scientifically formulated products for cognitive performance and everyday wellbeing, made properly and priced honestly.

This was made for you, so you can enjoy the same benefits without compromise.

“I wanted to build the products I couldn’t find when I needed them most: made properly, priced honestly, worth trusting.”

Dr Periklis Katopodis, Founder and CEO

Research

Peer reviewed publications

  1. Nephrogenic Ascites in End Stage Renal Disease: Pathophysiology, Clinical Features, and Management. Research Connections (2026)
  2. Non-Invasive Biomarkers in Assisted Reproductive Technologies, Current Evidence, Clinical Utility and Future Perspectives. Front. Reprod. Health (2026)
  3. Extracellular Matrix Remodeling and Matrix Metalloproteinases in Ovarian Function and Infertility. International Journal of Molecular Sciences (2026)
  4. Molecular Mechanisms of Dysregulated LH and FSH Secretion in Human Reproductive Failure. Biomedicines (2026)
  5. Leptin Receptor (LEPR) Mutations Disrupt Hypothalamic Control of the Reproductive Axis. International Journal of Molecular Sciences (2026)
  6. Genetic and Epigenetic Risks of Male Infertility in ART. International Journal of Molecular Sciences (2025)
  7. Reproductive Health and Assisted Conception in Celiac Disease and Non-Celiac Gluten Sensitivity: A Narrative Review. Nutrients (2025)
  8. Gut Microbiome Dysbiosis and Its Impact on Reproductive Health: Mechanisms and Clinical Applications. Metabolites (2025)
  9. Dietary and Lifestyle Interventions to Mitigate Oxidative Stress in Male and Female Fertility: Practical Insights for Infertility Management: A Narrative Review. Metabolites (2025)
  10. Oxidative Stress and the NLRP3 Inflammasome: Focus on Female Fertility and Reproductive Health. Cells (2025)
  11. Impact of Reductive Stress on Human Infertility: Underlying Mechanisms and Perspectives. International Journal of Molecular Sciences (2024)
  12. Impact of anaesthesia on perioperative inflammation in patients undergoing lung cancer resection. Journal of Cardiothorasic and Vascular Anesthesia (2023)
  13. Protein expression of transmembrane protease serine 4 in the gastrointestinal tract and in healthy, cancer, and SARS‑CoV‑2 infected lungs. Molecular medicine reports (2022)
  14. Differential expression of RAD51AP1 at protein level in ovarian cancer: effects of siRNA in vitro. Journal of Personalized Medicine (2022)
  15. Acid-base abnormalities and liver dysfunction. Annals of Hepatology (2022)
  16. Host cell entry mediators implicated in the cellular tropism of SARS-CoV-2 and the pathophysiology of COVID-19 and identification of microRNAs that can modulate their expression. International Journal of Molecular Medicine (2021)
  17. Circulating tumour cells and circulating cell-free DNA in lung cancer patients: A comparison between Thoracotomy and Video-Assisted Thoracoscopic Surgery. BMJ Open Respiratory Research (2021)
  18. p38β (MAPK11) and its role in female cancers. Journal of Ovarian Research (2021)
  19. COVID-19 and SARS-CoV-2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease. International Journal of Molecular Medicine (2021)
  20. Patient’s satisfactory outcomes after implementation of follow up “virtual clinic” in age related macular degeneration treatment. Clinical and Experimental Optometry (2021)
  21. Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID. International Journal of Oncology (2020)
  22. Pathophysiology of Drug-induced Hypomagnesemia. Drug Safety (2020)
  23. Image analysis of 3D conjunctival melanoma cell cultures following electrochemotherapy. Biomedicines (2020)
  24. Endometrial changes in estrogen and progesterone receptor expression during implantation in an oocyte donation program. Experimental and therapeutic medicine (2020)
  25. Molecular characteristics of Uveal Melanoma and intraocular tumors. Oncology reports (2020)
  26. In silico and in vitro analysis of lncRNA XIST reveals a panel of possible lung cancer regulators and a five-gene diagnostic signature. Cancers (2020)
  27. Kinase inhibitors in ovarian cancer. Cancers (2019)
  28. The Effect of Dialysis Modality and Membrane Performance on Native Immunity in Dialysis Patients. Prilozi (2019)
  29. Liquid Biopsies in Lung Cancer: Four Emerging Technologies and Potential Clinical Applications. Cancers (2019)
  30. Electrochemotherapy with bleomycin and cisplatin enhances cytotoxicity in primary and metastatic uveal melanoma cell lines in vitro. Neoplasma (2018)
  31. Conjunctival Melanoma and Electrochemotherapy: Preliminary results using 2D and 3D cell culture models in vitro. Acta Ophthalmologica (2018)
  32. Adipophilin expression in primary and metastatic uveal melanoma: a pilot study. Graefe's archive for clinical and experimental ophthalmology (2017)